Biosimilars
Size opportunities and threats in this lucrative market
Size the opportunity in this emerging space and evaluate disruptive effects
Assess the market size for biosimilars, optimize your market access strategy and determine how to best position your brand with comprehensive intelligence spanning regulatory pathways, payer policies, current treatment dynamics and competitive intel.
Leverage therapy area insights
Expert analyst team
Transformative intelligence to support your strategy
Keep track of emerging biosimilars
Evaluate the global biosimilars pipeline and launch timing in major markets.
Optimize your market access strategy
Track how payers and physicians respond to launches of biosimilars and understand the factors that will drive or limit use.
Inform strategic decision-making
Use actionable recommendations based on strategies used by both reference brand and biosimilar developers to defend and maximize their market share.
30
market sizing for over 30 reference brand biologics
10-year
interactive forecast covering the U.S., Europe and Japan
500+
physicians surveyed across six key specialties and in-depth interviews with U.S. and E.U. payers
